Institut Cancerologie De L'ouest

This early-phase trial is testing a new drug called ATO-101 for people with a type of bladder cancer (non-muscle-invasive) that has come back after standard treatments like BCG therapy. The drug delivers a short-range radioactive particle directly to cancer cells in the bladder, …

This early-phase study tests a precise radiation technique (stereotactic radiotherapy) in 18 men with advanced prostate cancer that has spread to bones or lymph nodes and is no longer responding to standard treatments. The goal is to find the largest total volume of tumors that c…

This study tests a non-invasive device that stimulates a nerve in the ear to reduce joint pain and stiffness caused by aromatase inhibitors, a common breast cancer treatment. About 60 women with hormone-positive breast cancer who experience joint pain will receive either the acti…

This study explores whether analyzing tumor DNA in urine can be a simple, non-invasive way to monitor prostate and bladder cancer. Researchers will collect urine samples from 25 patients at different treatment stages to find the best methods for collecting and analyzing the DNA. …

This study looks at breast cancer in women 45 and younger, focusing on how pregnancy and breastfeeding might influence the disease. Researchers will collect information on patients' reproductive history and analyze tumor samples. The goal is to better understand why breast cancer…